ANXA11 and frontotemporal dementia: Patient fibroblasts carrying the ALS-FTD-linked variants of ANXA11 showed considerably lower thapsigargin evoked Ca2+ release than the healthy control fibroblasts, indicating lower ER Ca2+ levels (Fig. 3B).